SCHEMBL809525

SCHEMBL809525

CCC(C)(C)c1cc(C(C)c2cc(C(C)(C)CC)cc(C(C)(C)CC)c2O)c(O)c(C(C)(C)CC)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
RORC P51449 1/20 0.37
MAPK1 P28482 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
MEN1 O00255 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RXRA P19793 4/20 0.33
PPARG P37231 4/20 0.33
RARG P13631 3/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
CASP3 P42574 1/20 0.33
RAB9A P51151 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13951874 0.95 CYP1A2 (0.48) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL6396629 0.92 CYP2C9 (0.50) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL12424224 0.91 CYP1A2 (0.36) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL21567921 0.91 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL29445881 0.91 CYP1A2 (0.40) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL16051015 0.88 CYP1A2 (0.42) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
Acrylic Acid SCHEMBL6447856 0.87 RXRA (0.39) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL6394325 0.87 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL30648248 0.87 CYP1A2 (0.39) CYP1A2CYP3A4CYP2C9TSHRCYP2C19
SCHEMBL29116202 0.85 RXRA (0.35) CYP1A2CYP3A4CYP2C9TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3000831-B1 PHOTOCURABLE ACRYLIC-BASED THERMAL CONDUCTIVE COMPOSITION, ACRYLIC-BASED THERMAL CONDUCTIVE SHEET, AND METHOD OF PRODUCING THE SAME DEXERIALS CORP (JP) 2018-11-07 EP claimed
JP-1168643-A None JP disclosed
JP-7061144-A None JP disclosed
US-20240166672-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-05-23 US disclosed
CN-110317453-B Organosilicon modified polyimide resin composition 信越化学工业株式会社 2024-02-13 CN disclosed
EP-4317166-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME Sumitomo Chemical Company Limited (JP) 2024-02-07 EP disclosed
WO-2022210295-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME, AND USE APPLICATION FOR SAME 住友化学株式会社 2022-10-06 WO disclosed
CN-105860371-A Waterproof building-out cable 安徽华宇电缆集团有限公司 2016-08-17 CN disclosed
EP-1666535-B1 RESIN COMPOSITION AND COMPOSITE USING THE COMPOSITION AND PRODUCTION PROCESS THEREOF DAICEL EVONIK LTD (JP) 2015-11-04 EP disclosed
US-8536258-B2 Stabilizer and method of manufacturing the same, thermoplastic polymer composition using the same, and method of stabilizing thermoplastic polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2013-09-17 US disclosed
EP-0583665-A2 Pharmaceutical composition and method for treating hyperlipidemia and arteriosclerosis FUJI PHOTO FILM CO., LTD. (JP) 1994-02-23 EP disclosed
US-5214193-A Coupling a dialkylphenol with aldehyde, esterification, crystallization SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-05-25 US disclosed
US-5128398-A Discoloration inhibition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-07-07 US disclosed
EP-0322166-B1 PHENOLIC COMPOUND AND ITS USE AS A STABILIZER FOR BUTADIENE POLYMER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1992-04-15 EP disclosed
JP-H01168643-A PHENOLIC COMPOUND AND STABILIZER CONTAINING SAID COMPOUND AS ACTIVE COMPONENT FOR BUTADIENE BASED POLYMER SUMITOMO CHEM CO LTD 1989-07-04 JP disclosed
EP-0322166-A1 Phenolic compound and its use as a stabilizer for butadiene polymer SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-06-28 EP disclosed
US-4558001-A ETHYLENE OXIDE ADDUCTS AND POLYMERS FUJI PHOTO FILM CO., LTD. (JP) 1985-12-10 US disclosed
US-4518354-A POLYOXYETHYLENE GLYCOL FUJI PHOTO FILM CO., LTD. (JP) 1985-05-21 US disclosed
US-4307187-A THIOSULFONIC ACIDS PREVENT HEAT FOG WHEN STORED, REDUCING AGENTS FUJI PHOTO FILM CO., LTD. (JP) 1981-12-22 US disclosed
US-4188212-A BEZNOTRIAZOLE FUJI PHOTO FILM CO., LTD. (JP) 1980-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166672-A1 PHOSPHOROUS ESTER COMPOUND, METHOD FOR PRODUCING SAME AND USE APPLICATION FOR SAME EBPL, ACSL6, ACSL3 CYP1A2 2764/4885CYP3A4 1171/4885CYP2C9 1363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.